We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Differentiation of Aseptic From Septic Loosening by 18F-fluoride PET

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01017562
First Posted: November 20, 2009
Last Update Posted: November 20, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Yokohama City University Medical Center
  Purpose
In this study, the investigators utilized the 18F-fluoride PET method to evaluate THA cases with a stable, septic or septic loosened implant in order to differentiate these clinical settings using a novel uptake type classification approach.

Condition
Hip Arthroplasty

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Differentiation of Aseptic From Septic Loosening in Patients With Total Hip Arthroplasty Using 18F-fluoride PET

Resource links provided by NLM:


Further study details as provided by Yokohama City University Medical Center:

Enrollment: 61
Study Start Date: April 2007
Study Completion Date: November 2009
Primary Completion Date: September 2009 (Final data collection date for primary outcome measure)
Groups/Cohorts
condition of joint implant

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients after total hip arthroplasty who agreed with the informed consent for this study.
Criteria

Exclusion Criteria:

  • Within one year after surgery
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01017562


Locations
Japan
Departement of orthopaedic sugery
Yokohama, Kanagawa, Japan, 236-0004
Sponsors and Collaborators
Yokohama City University Medical Center
Investigators
Principal Investigator: Naomi Kobayashi, MD, PhD. Department of orthopaedic surgey, Yokohama City University
  More Information

ClinicalTrials.gov Identifier: NCT01017562     History of Changes
Other Study ID Numbers: YCU21-106
First Submitted: November 19, 2009
First Posted: November 20, 2009
Last Update Posted: November 20, 2009
Last Verified: November 2009

Keywords provided by Yokohama City University Medical Center:
To clarify the 18F-fluoride uptake patterns associated with aseptic or septic loosening

Additional relevant MeSH terms:
Fluorides
Cariostatic Agents
Protective Agents
Physiological Effects of Drugs